LLY

#12
Eli Lilly & Co.
934.55 USD
+0.57%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
933.81
935.53
Rango anual
644.51
1 133.95
Cambio diario
+0.57%
Variación mensual
-5.87%
Variación en los últimos 6 meses
+15.02%
Cambio anual
+23.63%
Cierres anteriores
929.23
Abrir
934.63
Bid
Ask
Mínimo
933.81
High
935.53
Volumen
466
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 881.61 B
  • Employee 50 K
  • Founded N/A
  • CEO David A. Ricks
  • Website www.lilly.com
  • Headquarter Indiana, United States
  • FIGI BBG000BNBDC2
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
46.83
Relación precio/flujo de caja
14.83
Dividendos por acción
6.23
Rendimiento por dividendo, %
0.58

Eli Lilly and Company

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.

Noticias